Evidence that Ecotropic Murine Leukemia Virus Contamination in TZM-bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1

被引:196
|
作者
Platt, Emily J. [2 ]
Bilska, Miroslawa
Kozak, Susan L. [2 ]
Kabat, David [2 ]
Montefiori, David C. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Surg, Lab AIDS Vaccine Res & Dev, Durham, NC 27710 USA
[2] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA
关键词
AMINO-ACID TRANSPORTER; C INFECTION; RETROVIRUSES; EXPRESSION; RECEPTOR; HIV-1; IDENTIFICATION; INTERFERENCE; EPITOPE; FUSION;
D O I
10.1128/JVI.00709-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The TZM-bl cell line that is commonly used to assess neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) was recently reported to be contaminated with an ecotropic murine leukemia virus (MLV) (Y. Takeuchi, M. O. McClure, and M. Pizzato, J. Virol. 82: 12585-12588, 2008), raising questions about the validity of results obtained with this cell line. Here we confirm this observation and show that HIV-1 neutralization assays performed with a variety of serologic reagents in a similar cell line that does not harbor MLV yield results that are equivalent to those obtained in TZM-bl cells. We conclude that MLV contamination has no measurable effect on HIV-1 neutralization when TZM-bl cells are used as targets for infection.
引用
收藏
页码:8289 / 8292
页数:4
相关论文
共 50 条
  • [41] Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection
    Frost, SDW
    Wrin, T
    Smith, DM
    Pond, SLK
    Liu, Y
    Paxinos, E
    Chappey, C
    Galovich, J
    Beauchaine, J
    Petropoulos, CJ
    Little, SJ
    Richman, DD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) : 18514 - 18519
  • [42] The LEM domain proteins emerin and LAP2α are dispensable for human immunodeficiency virus type 1 and murine leukemia virus infections
    Mulky, Alok
    Cohen, Tatiana V.
    Kozlov, Serguei V.
    Korbei, Barbara
    Foisner, Roland
    Stewart, Colin L.
    KewalRarnani, Vineet N.
    JOURNAL OF VIROLOGY, 2008, 82 (12) : 5860 - 5868
  • [43] Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants
    Dickover, Ruth
    Garratty, Eileen
    Yusim, Karina
    Miller, Catherine
    Korber, Bette
    Bryson, Yvonne
    JOURNAL OF VIROLOGY, 2006, 80 (13) : 6525 - 6533
  • [44] The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection
    Binley, JM
    Trkola, A
    Ketas, T
    Schiller, D
    Clas, B
    Little, S
    Richman, D
    Hurley, A
    Markowitz, M
    Moore, JP
    JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03): : 945 - 949
  • [45] Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen
    Corey, L
    McElrath, MJ
    Weinhold, K
    Matthews, T
    Stablein, D
    Graham, B
    Keefer, M
    Schwartz, D
    Gorse, G
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (02): : 301 - 309
  • [46] Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells
    Frankel, SS
    Steinman, RM
    Michael, NL
    Kim, SR
    Bhardwaj, N
    Pope, M
    Louder, MK
    Ehrenberg, PK
    Parren, PWHI
    Burton, DR
    Katinger, H
    VanCott, TC
    Robb, ML
    Birx, DL
    Mascola, JR
    JOURNAL OF VIROLOGY, 1998, 72 (12) : 9788 - 9794
  • [47] Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus
    Kim, FJ
    Seiliez, I
    Denesvre, C
    Lavillette, D
    Cosset, FL
    Sitbon, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) : 23417 - 23420
  • [48] The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate
    Conley, AJ
    Kessler, JA
    Boots, LJ
    McKenna, PM
    Schleif, WA
    Emini, EA
    Mark, GE
    Katinger, H
    Cobb, EK
    Lunceford, SM
    Rouse, SR
    Murthy, KK
    JOURNAL OF VIROLOGY, 1996, 70 (10) : 6751 - 6758
  • [49] Primary virus envelope cross-reactivity of the broadening neutralizing antibody response during early chronic human immunodeficiency virus type 1 infection
    Zhang, PF
    Chen, X
    Fu, DW
    Margolick, JB
    Quinnan, GV
    JOURNAL OF VIROLOGY, 1999, 73 (06) : 5225 - 5230
  • [50] A BROADLY NEUTRALIZING HUMAN MONOCLONAL-ANTIBODY AGAINST GP41 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PURTSCHER, M
    TRKOLA, A
    GRUBER, G
    BUCHACHER, A
    PREDL, R
    STEINDL, F
    TAUER, C
    BERGER, R
    BARRETT, N
    JUNGBAUER, A
    KATINGER, H
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (12) : 1651 - 1658